Simon Collins blog

Simon reports on treatment news and HIV research. He edits HIV Treatment Bulletin (HTB) and the i-Base treatment guides and co-ordinates the i-Base treatment information services. He has been an advocate for over 15 years.

PrEP talk from Glasgow online as a webcast

Friends slide PrEPA couple of weeks ago I gave a talk about PrEP from a community perspective to the HIV conference in Glasgow.

The talk lasts for 20 minutes with questions afterwards and is now available as a webcast on the conference website.

As part of the same session, Stefano Vella gave an excellent talk on Treatment as Prevention just before – also recommended. There are separate links for each talk.

PowerPoint and PDF versions fo the slides are available on the i-Base website, together with previous workshop resources.

Both PrEP and TasP are likely to help dramatically reduce stigma against HIV. Understanding their impact on transmission risk has the potential to normalise HIV. They both can contribute to removing some of the fear that persists in reducing the quality of people’s lives – whether they are HIV positive or HIV negative.

The talk tackles a few common myths and makes the case that:

  1. PrEP is not driven by a commercial motives of drug companies.
  2. PrEP is clearly effective, perhaps more so than condoms, but only if you are able to take it.
  3. PrEP is most effective when used by people who are already at high risk from not using condoms. Even them this might be for a short period in their life. It is not tying to negate the benefits of condoms and it is likely to be a choice that perhaps only a minority of people want to use.

Following early efficacy results announced last month from the PROUD and IPERGAY studies, there is an urgency to offer PrEP in the UK to those who otherwise are likely to test HIV positive next year.

Any feedback is appreciated.

  1. The PROUD study: access to PrEP in the UK to prevent HIV Add comment
  2. HIV and young gay people in London: two short online videos Add comment
  3. UK changes PEP meds: raltegravir replaces PIs 2 Replies
  4. HIV, gay men and drug use: ASTRA study and comment in The Lancet HIV Add comment
  5. START study open DSMB report (May 2014) Add comment
  6. Generic ARVs in the UK – background paper for drug commissioning Add comment
  7. The importance of evidence for “When to Start”: a response to Dr Myron Cohen Add comment
  8. Pictures from the march in Washington Add comment
  9. Film review: How to survive a plague – the early years of ACT-UP New York Add comment
  10. IAS 2012 webcasts – now online with live streaming Add comment
  11. START study: enrolling well, open DSMB report shows no concerns Add comment